Ortho Biotech Oncology Research & Development

BEERSE, Belgium, December 4 - Ortho Biotech Oncology Research & Development, a division of Janssen Pharmaceutica N.V., today announced that data related to several of its oncology compounds will be presented at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana, from December 5th to December 8th, 2009.